Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 28,784 shares at $208.55 ($6.0M) on 2021-02-09, disclosed to the SEC on 2021-02-11.
Open-market sale of $6.0M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $208.00 | 556 | $116K | 1.9% |
| 2 | $208.55 | 14,114 | $2.9M | 49.0% |
| 3 | $208.55 | 14,114 | $2.9M | 49.0% |
| Total | $208.54 avg | 28,784 | $6.0M | 100% |
| Filing → |
| LGND | SELL | 2026-03-05 | $410K | — | Filing → |
| LGND | SELL | 2024-03-07 | $281K | — | Filing → |
| LGND | SELL | 2023-05-12 | $988K | — | Filing → |